|
ZCCHC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.0944000150559E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.69440000205879E-08 |
| Normal-vs-Stage2 |
6.47590000000253E-05 |
| Normal-vs-Stage3 |
3.55300000531855E-08 |
| Normal-vs-Stage4 |
1.96609999947306E-07 |
| Stage1-vs-Stage2 |
9.941600E-01 |
| Stage1-vs-Stage3 |
2.395000E-01 |
| Stage1-vs-Stage4 |
2.795000E-01 |
| Stage2-vs-Stage3 |
4.366400E-01 |
| Stage2-vs-Stage4 |
3.804400E-01 |
| Stage3-vs-Stage4 |
8.787800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.98459999545264E-08 |
| Normal-vs-AfricanAmerican |
2.241800E-03 |
| Normal-vs-Asian |
2.37049999999295E-05 |
| Caucasian-vs-AfricanAmerican |
8.279400E-01 |
| Caucasian-vs-Asian |
8.925000E-01 |
| AfricanAmerican-vs-Asian |
7.798600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.369899997414E-08 |
| Normal-vs-Female |
4.7209000042514E-09 |
| Male-vs-Female |
8.748600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.26400000022286E-07 |
| Normal-vs-Age(41-60Yrs) |
3.78629999575608E-08 |
| Normal-vs-Age(61-80Yrs) |
7.88670000417824E-08 |
| Normal-vs-Age(81-100Yrs) |
7.701500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.831400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.991200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.439800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.228200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.276600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.793600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.055450E-03 |
| Classical-VS-Follicular |
2.19479999999939E-05 |
| Classical-VS-Other |
2.545000E-01 |
| Classical-VS-Normal |
2.46589999997049E-06 |
| Tall-VS-Follicular |
8.667600E-01 |
| Tall-VS-Other |
8.092400E-01 |
| Tall-VS-Normal |
1.73419999471847E-08 |
| Follicular-VS-Other |
7.835000E-01 |
| Follicular-VS-Normal |
8.393097328252E-11 |
| Other-VS-Normal |
7.600300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.20039986231768E-10 |
| Normal-vs-N1 |
6.92229999987859E-07 |
| N0-vs-N1 |
9.390200E-01 |
|
|
